Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation

Bone Marrow Transplantation volume 46, pages 1167–1185 (2011)Cite this article

Subjects

Abstract

Transplantation of hematopoietic progenitor cells from red cell-incompatible donors occurs in 30–50% of patients. Immediate and delayed hemolytic transfusion reactions are expected complications of red cell-disparate transplantation and both ABO and other red cell systems such as Kidd and rhesus can be involved. The immunohematological consequences of red cell-incompatible transplantation include delayed red blood cell recovery, pure red cell aplasia and delayed hemolysis from viable lymphocytes carried in the graft (‘passenger lymphocytes’). The risks of these reactions, which may be abrupt in onset and fatal, are ameliorated by graft processing and proper blood component support. Red blood cell antigens are expressed on endothelial and epithelial tissues in the body and could serve to increase the risk of GvHD. Mouse models indicate that blood cell antigens may function as minor histocompatibility antigens affecting engraftment. Similar observations have been found in early studies of human transplantation for transfused recipients, although current conditioning and immunosuppressive regimens appear to overcome this affect. No deleterious effects from the use of red cell-incompatible hematopoietic grafts on transplant outcomes, such as granulocyte and platelet engraftments, the incidences of acute or chronic GvHD, relapse risk or OS, have been consistently demonstrated. Most studies, however, include limited number of patients, varying diagnoses and differing treatment regimens, complicating the detection of an effect of ABO-incompatible transplantation. Classification of patients by ABO phenotype ignoring the allelic differences of these antigens also may obscure the effect of red cell-incompatible transplantation on transplant outcomes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Mielcarek M, Leisenring W, Torok-Storb B, Storb R . Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect. Blood 2000; 96: 1150–1156.

    CAS  PubMed  Google Scholar 

  2. Kimura F, Sato K, Kobayashi S, Ikeda T, Sao H, Okamoto S et al. Impact of ABO-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program. Haematologica 2008; 93: 1686–1693.

    Article  PubMed  Google Scholar 

  3. Logdberg L, Reid ME, Zelinski T . Human blood group genes 2010: chromosomal locations and cloning strategies revisited. Transfus Med Rev 2011; 25: 36–46.

    Article  PubMed  Google Scholar 

  4. Ried ME, Lomas-Francis C . The Blood Group Antigen Facts Book, 2nd edn. Elsevier Academic Press: New York, 2004.

    Google Scholar 

  5. Franchini M, de Gironcoli M, Gandini G, Vassanelli A, Rocca P, Benedetti F et al. Transmission of an anti-RhD alloantibody from donor to recipient after ABO-incompatible BMT. Bone Marrow Transplant 1998; 21: 1071–1073.

    Article  CAS  PubMed  Google Scholar 

  6. Leo A, Mytilineos J, Voso MT, Weber-Nordt R, Liebish P, Lensing C et al. Passenger lymphocyte syndrome with severe hemolytic anemia due to an anti-Jka after allogeneic PBPC transplantation. Transfusion 2000; 40: 632–636.

    Article  CAS  PubMed  Google Scholar 

  7. Seebach JD, Stussi G, Passweg JR, Loberiza FR, Gajewski JL, Keating A et al. ABO blood group barrier in allogeneic bone marrow transplantation revisited. Biol Blood Marrow Transplant 2005; 11: 1006–1013.

    Article  PubMed  Google Scholar 

  8. Michallet M, Le Q-H, Mohty M, Prebet T, Nicolini R, Boiron JM et al. Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire. Exp Hematol 2008; 36: 535–544.

    Article  PubMed  Google Scholar 

  9. Kollman C, Howe CW, Anasetti C, Antin JH, Davies SM, Filipovich AH et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001; 98: 2043–2051.

    Article  CAS  PubMed  Google Scholar 

  10. Canals C, Muniz-Diaz E, Martinez C, Martino R, Moreno I, Ramos A et al. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantations afterreduced intensity conditioning. Transfusion 2004; 44: 1603–1611.

    Article  PubMed  Google Scholar 

  11. Worel N, Kalhs P, Keil F, Prinz E, Moser K, Schulenberg A et al. ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation. Transfusion 2003; 43: 1153–1161.

    Article  PubMed  Google Scholar 

  12. Kim JG, Sohn SK, Kim DH, Baek JH, Lee KB, Min WS et al. Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2005; 35: 489–495.

    Article  CAS  PubMed  Google Scholar 

  13. Gale RP, Feig S, Ho W, Falk P, Rippee C, Sparkes R . ABO blood group system and bone marrow transplantation. Blood 1977; 50: 185–194.

    CAS  PubMed  Google Scholar 

  14. Buckner CD, Clift RA, Sanders JE, Williams B, Gray M, Storb R et al. ABO-incompatible marrow transplants. Transplantation 1978; 26: 233–238.

    Article  CAS  PubMed  Google Scholar 

  15. Bensinger WI, Buckner CD, Thomas ED, Clift RA . ABO-incompatible marrow transplants. Transplantation 1982; 33: 427–429.

    Article  CAS  PubMed  Google Scholar 

  16. Bacigalupo A, Van Lint MT, Occhini D, Ferrari G, Pittaluga PA, Frassoni F et al. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation. Transplantation 1988; 45: 1091–1094.

    Article  CAS  PubMed  Google Scholar 

  17. Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D et al. Analysis of risk factors for the development of GvHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Biol Blood Marrow Transplant 2001; 7: 620–630.

    Article  CAS  PubMed  Google Scholar 

  18. Benjamin RJ, McGurk S, Ralston MS, Churchill WH, Antin JH . ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion 1999; 39: 178–187.

    Google Scholar 

  19. Helming AM, Brand A, Wolterbeek R, van Tol MJ, Egeler RM, Ball LM . ABO incompatible stem cell transplantation in children does not influence outcome. Pediatr Blood Cancer 2007; 49: 313–317.

    Article  CAS  PubMed  Google Scholar 

  20. Mehta J, Powles R, Sirohi B, Treleaven J, Kulkarni S, Saso R et al. Does donor–recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia? Bone Marrow Transplant 2002; 29: 853–859.

    Article  CAS  PubMed  Google Scholar 

  21. Tomonari A, Takahashi S, Ooi J, Tsukada N, Konuma T, Kobayashi T et al. Impact of ABO incompatibility on engraftment and transfusion requirement after unrelated cord blood transplantation: a single institute experience in Japan. Bone Marrow Transplant 2007; 40: 523–528.

    Article  CAS  PubMed  Google Scholar 

  22. Wang Z, Sorror ML, Leisenring W, Schoch G, Maloney DG, Sandmaier BM et al. The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation. Br J Haematol 2010; 149: 101–110.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Resnick IB, Tsirigotis PD, Shapira MY, Aker M, Bitan M, Samuel S et al. ABO incompatibility is associated with increased non-relapse and GvHD mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patients. Biol Blood Marrow Transplant 2008; 14: 409–417.

    Article  CAS  PubMed  Google Scholar 

  24. Storb R, Prentice RL, Thomas ED . Marrow Transplantation for treatment of aplastic anemia. An analysis of factors associated with gaft rejection. N Engl J Med 1977; 296: 61–66.

    Article  CAS  PubMed  Google Scholar 

  25. Stussi G, Muntwyler J, Passweg JR, Seebach L, Schanz U, Gmur J et al. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 30: 87–93.

    Article  CAS  PubMed  Google Scholar 

  26. Erker CG, Steins MB, Fischer R-J, Kienast W, Berdel WE, Sibrowski W et al. The influence of blood group differences in allogeneic hematopoietic peripheral blood progenitor cell transplantation. Transfusion 2005; 45: 1382–1390.

    Article  PubMed  Google Scholar 

  27. Blin N, Traineau R, Houssin S, Peffault de LaTour R, Petropoulou A, Robin M et al. Impact of donor–recipient ABO mismatch on allogeneic transplantation outcome according to stem cell source. Biol Blood Marrow Transplant 2010; 16: 1315–1323.

    Article  PubMed  Google Scholar 

  28. Ozkurt ZN, Yegin ZA, Yenicesu I, Aki SZ, Yagci M, Sucak GT . Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation. Transplant Proc 2009; 41: 3851–3858.

    Article  CAS  PubMed  Google Scholar 

  29. Kalacioglu M, Copelan E, Avalos B, Klein J, Goormastic M, Bolwell B . Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide. Bone Marrow Transplant 1995; 15: 105–110.

    Google Scholar 

  30. Klummp TR, Herman JH, Ulicny J, Emmons RVB, Martin ME, Mangin KF . Lack of effect of donor–recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2006; 38: 615–620.

    Article  Google Scholar 

  31. Goldman J, Liesveld J, Nichols D, Heal J, Blumberg N . ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation. Leuk Res 2003; 27: 489–491.

    Article  PubMed  Google Scholar 

  32. Rozman P, Kosir A, Bohinjec M . Is the ABO incompatibility a risk factor in bone marrow transplantation? Transplant Immunol 2005; 14: 159–169.

    Article  CAS  Google Scholar 

  33. Kanda J, Ichinohe T, Matsuo K, Benjamin RJ, Klumpp TR, Rozman P et al. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies; IPD-based meta-analysis of cohort studies. Transfusion 2009; 49: 624–635.

    Article  PubMed  Google Scholar 

  34. Adams BR, Miller AN, Costa LJ . Self-limited hemolysis due to anti-D passenger lymphocyte syndrome in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2010; 45: 772–773.

    Article  CAS  PubMed  Google Scholar 

  35. Loren AW, Bunin GR, Boudreau C, Champlin RE, Cnaan A, Horowitz MM et al. Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 758–769.

    Article  PubMed  Google Scholar 

  36. Daniel-Johnson J, Leitman S, Klein H, Alter H, Lee-Stroka A, Scheinberg P et al. Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions. Transfusion 2009; 49: 1845–1849.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Olsson MJ, Chester MA . Polymorphism and recombination events at the ABO locus: a major challenge for genomic ABO blood grouping strategies. Transfus Med 2001; 11: 295–313.

    Article  CAS  PubMed  Google Scholar 

  38. Eiz-Vesper B, Seltsam A, Blasczyk R . ABO glycosyltransferases as potential source of minor histocompatibility antigens in allogeneic peripheral blood progenitor cell transplantation. Transfusion 2005; 45: 960–968.

    Article  CAS  PubMed  Google Scholar 

  39. Daniels G . Functions of red cell surface proteins. Vox Sang 2007; 93: 331–340.

    Article  CAS  PubMed  Google Scholar 

  40. Cartron JP, Colin Y . Structural and functional diversity of blood group antigens. Transfus Clin Biol 2001; 8: 163–199.

    Article  CAS  PubMed  Google Scholar 

  41. Weiden PL, Storb R, Thomas ED, Graham TC, Lerner KG, Buckner CD et al. Preceding transfusions and marrow graft rejection in dogs and man. Transplant Proc 1976; 8: 551–554.

    CAS  PubMed  Google Scholar 

  42. Storb R, Thomas ED, Buckner CD, Clift RA, Deeg HJ, Fefer A et al. Marrow transplantation in thirty ‘untransfused’ patients with severe aplastic anemia. Ann Intern Med 1980; 92: 30–36.

    Article  CAS  PubMed  Google Scholar 

  43. Storb R, Weiden PL, Deeg HJ, Graham TC, Atkinson K, Slichter SJ et al. Rejection of marrow from DLA-identical canine littermates given transfusions before grafting: antigens involved are expressed on leukocytes and skin epithelial cells but not on platelets and red blood cells. Blood 1979; 54: 477–484.

    CAS  PubMed  Google Scholar 

  44. Desmerets M, Cadwell CM, Peterson KR, Neades R, Zimring JC . Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model. Blood 2009; 114: 2315–2322.

    Article  CAS  Google Scholar 

  45. Patel SR, Cadwell CM, Medford A, Zimring JC . Transfusion of minor histocompatibility antigen-mismatched platelets induces rejection of bone marrow transplants in mice. J Clin Invest 2009; 119: 2787–2794.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Bean MA, Storb R, Graham T, Raff T, Sale GE, Schuening F et al. Prevention of transfusion-induced sensitization to minor histocompatibility antigens on DNA-identical canine marrow grafts by gamma irradiation of marrow donor blood. Transplantation 1991; 52: 956–960.

    Article  CAS  PubMed  Google Scholar 

  47. Bean MA, Graham T, Appelbaum FR, Deeg HJ, Schuening F, Sale GE et al. Gamma-irradiation of pretransplant blood transfusions from unrelated donors prevents sensitization to minor histocompatibility antigens on dog leukocyte antigen-identical canine marrow grafts. Transplantation 1994; 57: 423–426.

    Article  CAS  PubMed  Google Scholar 

  48. Rozman P, Karas M, Kosir A, Labar B, Madrigal A, Middleton D et al. Are human platelet alloantigens (HPA) minor transplantation antigens in clinical bone marrow transplantation? Bone Marrow Transplant 2003; 31: 497–506.

    Article  CAS  PubMed  Google Scholar 

  49. Cooling LL, Kelly K, Barton J, Hwang D, Koerner TA, Olson JD . Determinants of ABH expression on human blood platelets. Blood 2005; 105: 3356–3364.

    Article  CAS  PubMed  Google Scholar 

  50. Weissinger F, Sandmaier BM, Maloney DG, Bensinger WI, Golley T, Storb R et al. Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cells transplants from HLA-identical siblings. Blood 2001; 98: 3584–3588.

    Article  CAS  PubMed  Google Scholar 

  51. Remberger M, Watz E, Ringden O, Mattson J, Shanwell A, Wikman A . Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 675–681.

    Article  PubMed  Google Scholar 

  52. Badros A, Tricot G, Toor A, Morris C, Guo C, Munshi N et al. ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning. Transfusion 2002; 42: 205–209.

    Article  PubMed  Google Scholar 

  53. Ravn V, Dabelsteen E . Tissue distribution of histo-blood group antigens. APMIS 2000; 108: 1–28.

    Article  CAS  PubMed  Google Scholar 

  54. Ting A, Pun A, Dodds AJ, Atkinson K, Biggs JC . Red cell alloantibodies produced after bone marrow transplantation. Transfusion 1987; 27: 145–147.

    Article  CAS  PubMed  Google Scholar 

  55. Abou-Elella AA, Camarillo TA, Allen MB, Barclay S, Pierce JA, Holland HK et al. Low incidence of red cell and HLA antibody formation by bone marrow transplant patients. Transfusion 1995; 35: 931–935.

    Article  CAS  PubMed  Google Scholar 

  56. de la Rubia J, Arriaga F, Andreu R, Sanz G, Jimenez C, Vicente A et al. Development of non-ABO RBC alloantibodies in patients undergoing allogeneic HPC transplantation. Is ABO incompatibility a predisposing factor? Transfusion 2001; 41: 106–110.

    Article  CAS  PubMed  Google Scholar 

  57. Zupanska B, Saucha MJ, Michalewska B, Malinowska A, Brojer E, Hellmann A . Multiple red cell alloantibodies, including anti-Dib, after allogeneic ABO-matched peripheral blood progenitor cell transplantation. Transfusion 2005; 45: 16–20.

    Article  PubMed  Google Scholar 

  58. Lopez A, de la Rubia J, Arriaga F, Jimenez C, Sanz GF, Carpio N et al. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant. Transfusion 1998; 38: 247–251.

    Article  CAS  PubMed  Google Scholar 

  59. Young PP, Goodnough LT, Westervelt P, Dipersio JF . Immune hemolysis involving non-ABO/RhD alloantibodies following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 1305–1310.

    Article  CAS  PubMed  Google Scholar 

  60. Wirk B, Klumpp TR, Ulicny J, Herman JH, Gajewski JL, Martin ME et al. Lack of effect of donor–recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation. Transfusion 2008; 48: 163–168.

    PubMed  Google Scholar 

  61. Korbling M, Huh YO, Durett A, Mirza N, Miller P, Engel P et al. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995; 86: 2842–2848.

    CAS  PubMed  Google Scholar 

  62. Larghero J, Rea D, Esperou H, Biscay N, Maurer MN, Lacassangne M et al. ABO-mismatched marrow processing for transplantation: results of 114 procedures and analysis of immediate adverse events and hematopoietic recovery. Transfusion 2006; 46: 398–402.

    Article  CAS  PubMed  Google Scholar 

  63. Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995; 92: 10119–10122.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Rowley SD, Prather K, Bui KT, Appel M, Felt T, Bensinger WI . Collection of peripheral blood progenitor cells with an automated leukapheresis system. Transfusion 1999; 39: 1200–1206.

    Article  CAS  PubMed  Google Scholar 

  65. Snell M, Chau C, Hendrix D, Fox R, Downes KA, Creger R et al. Lack of isohemagglutinin production following minor ABO incompatible unrelated HLA mismatched umbilical cord blood transplantation. Bone Marrow Transplant 2006; 38: 135–140.

    Article  CAS  PubMed  Google Scholar 

  66. Janatpour KA, Kalmin ND, Jensen HM, Holland PV . Clinical outcomes of ABO-incompatible RBC transfusions. Am J Clin Pathol 2008; 129: 276–281.

    Article  PubMed  Google Scholar 

  67. Stroncek DF, Clay ME, Smith J, Herr S, Ilstrup SJ, Kunkel LA et al. Composition of peripheral blood progenitor cell components collected from healthy donors. Transfusion 1997; 37: 411–417.

    Article  CAS  PubMed  Google Scholar 

  68. Scholl S, Klink A, Mugge L-O, Schilling K, Hoffken K, Sayer HG . Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch. Transfusion 2005; 45: 1676–1683.

    Article  PubMed  Google Scholar 

  69. Braine HG, Sensenbrenner LL, Wright SK, Tutschka PJ, Saral R, Santos GW . Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion. Blood 60; 1982: 420–425.

    Google Scholar 

  70. Warkentin PI, Hilden JM, Kersey JH, Ramsay NK, McCullough J . Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch. Vox Sang 1985; 48: 89–104.

    Article  CAS  PubMed  Google Scholar 

  71. Tsang KS, Li CK, Wong AP, Leung Y, Lau TT, Li K et al. Processing of major ABO-incompatible bone marrow for transplantation by using dextran sedimentation. Transfusion 1999; 39: 1212–1219.

    Article  CAS  PubMed  Google Scholar 

  72. Bensinger WI, Buckner CD, Clift RA, Thomas ED . Plasma exchange and plasma modification for the removal of anti-red cell antibodies prior to ABO-incompatible marrow transplant. J Clin Apher 1987; 3: 174–177.

    Article  CAS  PubMed  Google Scholar 

  73. Stussi G, Halter J, Bucheli E, Valli PV, Seebach L, Gmur J et al. Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins. Haematologica 2009; 94: 239–248.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Tobian AAR, Shirey RS, Montgomery RA, Tisch DJ, Ness PM, King KE . Therapeutic plasma exchange reduces ABO titers to permit ABO-incompatible renal transplantation. Transfusion 2009; 49: 1248–1254.

    Article  CAS  PubMed  Google Scholar 

  75. Geyer M, Fischer K-G, Drognitz O, Walz G, Pisarski P, Wilpert J . ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab—insights and uncertainties. Contrib Nephrol 2009; 162: 47–60.

    Article  CAS  PubMed  Google Scholar 

  76. Rowley SD, Liang PS, Ulz L . Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components. Bone Marrow Transplant 2000; 26: 749–757.

    Article  CAS  PubMed  Google Scholar 

  77. Lee JH, Lee JH, Choi SJ, Kim S, Seol M, Kwon SW et al. Changes of isoagglutinin titres after ABO-incompatible allogeneic stem cell transplantation. Br J Haematol 2003; 120: 702–710.

    Article  CAS  PubMed  Google Scholar 

  78. Bolan CD, Leitman SF, Griffith LM, Wesley RA, Procter JL, Stroncek DR et al. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood 2001; 98: 1687–1694.

    Article  CAS  PubMed  Google Scholar 

  79. Southcott MJ, Tanner MJ, Anstee DJ . The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood 1999; 93: 4425–4435.

    CAS  PubMed  Google Scholar 

  80. Bony V, Gane P, Bailly P, Cartron JP . Time-course expression of polypeptides carrying blood group antigens during human erythroid differentiation. Br J Haematol 1999; 107: 263–274.

    Article  CAS  PubMed  Google Scholar 

  81. Helbig G, Stella-Holowiecka B, Krawczyk-Kulis M, Wojnar J, Markiewicz M, Wojciechowska-Sadus M et al. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukemia. Haematologica 2005; 90: e93–e96.

    Google Scholar 

  82. Dahl D, Hahn A, Koenecke C, Heuft HG, Dammann E, Stadler M et al. Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk. Transfusion 2010; 50: 649–655.

    Article  PubMed  Google Scholar 

  83. Griffith LM, McCoy JP, Bolan CD, Stroncek DF, Pickett AC, Linton GF et al. Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation. Br J Haematol 2005; 128: 668–675.

    Article  CAS  PubMed  Google Scholar 

  84. Schetelig J, Breitschaft A, Kroger N, Zabelinn T, Ebell W, Bornhauser M et al. After major ABO-mismatched allogeneic hematopoietic progenitor cell transplantation, erythroid engraftment occurs later in patients with donor blood group A than donor blood group B. Transfusion 2005; 45: 779–787.

    Article  PubMed  Google Scholar 

  85. Maciej Zaucha J, Mielcarek M, Takatu A, Little MT, Gooley T, Baker J et al. Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation. Br J Haematol 2002; 119: 740–750.

    Article  CAS  PubMed  Google Scholar 

  86. Gmur JP, Burger J, Schaffner A, Neftel K, Oelz O, Frey D et al. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood 1990; 75: 290–295.

    CAS  PubMed  Google Scholar 

  87. Heyll A, Aul C, Runde V, Arning M, Schneider W, Wernet P . Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin. Blood 1991; 77: 906.

    CAS  PubMed  Google Scholar 

  88. Santamaria A, Sureda A, Martino R, Domingo-Albos A, Muniz-Diaz E, Brunet S . Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin. Bone Marrow Transplant 1997; 20: 1105–1107.

    Article  CAS  PubMed  Google Scholar 

  89. Paltiel O Cournoyer D, Rybka W . Pure red cell aplasia following ABO-incompatible bone marrow transplantation: response to erythropoietin. Transfusion 1993; 33: 418–421.

    Article  PubMed  Google Scholar 

  90. Benjamin RJ, Connors JM, McGurk S, Churchill WH, Antin JH . Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia. Biol Blood Marrow Transplant 1998; 4: 151–156.

    Article  CAS  PubMed  Google Scholar 

  91. Maschan AA, Skorobogatova EV, Balashov DN, Pashanov ED, Trakhtman PE, Schipitzina IP et al. Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cells transplantation for acquired aplastic anemia. Bone Marrow Transplant 2002; 30: 405–407.

    Article  CAS  PubMed  Google Scholar 

  92. Sora F, De Matteis S, Piccirillo N, Chiusolo P, Laurenti L, Putzulu et al. Rituximab for pure red cell aplasia after ABO-mismatched allogeneic peripheral blood progenitor cell transplantation. Transfusion 2005; 45: 643–644.

    Article  PubMed  Google Scholar 

  93. Zand MS . B-cell activity of polyclonal antithymocyte globulins. Transplantation 2006; 82: 1387–1395.

    Article  CAS  PubMed  Google Scholar 

  94. Labar B, Bogdanic V, Nemet D, Kovacevic-Metelko J, Mrsic M, Pavletic Z et al. Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant. Bone Marrow Transplant 1992; 10: 471–472.

    CAS  PubMed  Google Scholar 

  95. Bierman PJ, Warkentin P, Hutchins MR, Klassen LW . Pure red cell aplasia following ABO mismatched marrow transplantation for chronic lymphocyte leukemia: response to antithymocyte globulin. Leuk Lymphoma 1993; 9: 169–171.

    Article  CAS  PubMed  Google Scholar 

  96. Roychowdhury DF, Linker CA . Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin. Bone Marrow Transplant 1995; 16: 471–472.

    CAS  PubMed  Google Scholar 

  97. Verholen F, Stalder M, Heig C, Chalandon Y . Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion. Eur J Haematol 2004; 73: 441–446.

    Article  CAS  PubMed  Google Scholar 

  98. Ebihara Y, Manabe A, Tsuruta T, Ishikawa K, Haseqawa D, Ohtsuka Y et al. The effect of donor leukocyte infusion on refractory pure red blood cell aplasia after allogeneic stem cell transplantation in a patient with myelodysplastic syndrome developing from Kostmann Syndrome. Int J Hematol 2007; 86: 446–450.

    Article  PubMed  Google Scholar 

  99. Ramsey G, Smietana SJ . Long-term follow-up of red cell alloantibodies. Transfusion 1994; 34: 122–124.

    Article  CAS  PubMed  Google Scholar 

  100. Happ WM . Appearance of isoagglutinins in infants and children. J Exp Med 1920; 29: 313–314.

    Article  Google Scholar 

  101. Rowley S, Braine H . Probable hemolysis following minor ABO incompatible marrow transplantation. Blood 1982; 60: 171a.

    Google Scholar 

  102. Moog R, Melder C, Prumbaum M, Muller N, Schaefer UW . Rapid donor type isoagglutinins production after allogeneic peripheral progenitor cell transplantation. Beitr Infusions Ther Transfus Med 1997; 34: 150–152.

    CAS  Google Scholar 

  103. Hoegler W, Nachbauer D, Kropshofer G, Wehl G, Schoenitzer D, Nussbaumer W . Abrupt onset of severe passenger lymphocyte syndrome after HLA-mismatched unrelated bone marrow transplantation in a seven-year-old boy. Med Pediatr Oncol 2002; 38: 143–144.

    Article  PubMed  Google Scholar 

  104. Greeno EW, Perry EH, Ilstrup SJ, Weisdorf DJ . Exchange transfusion the hard way: massive hemolysis following transplantation of bone marrow with minor ABO incompatibility. Transfusion 1996; 36: 71–74.

    Article  CAS  PubMed  Google Scholar 

  105. Reed M, Yearsley M, Krugh D, Kennedy M . Severe hemolysis due to passenger lymphocyte syndrome after hematopoietic stem cell transplantation from an HLA-matched related donor. Arch Pathol Lab Med 2003; 127: 1366–1368.

    PubMed  Google Scholar 

  106. Curtin NJ, Schwarer AP . Nonmyeloablative peripheral blood stem cell transplant for T-cell prolymphocytic leukaemia complicated by fulminant haemolysis and acute renal failure at engraftment secondary to minor ABO incompatibility. Clin Lab Haem 2005; 27: 206–208.

    Article  CAS  Google Scholar 

  107. Hows J, Beddow K, Gordon-Smith E, Branch DR, Spruce W, Sniecinski I et al. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood 1986; 67: 177–181.

    CAS  PubMed  Google Scholar 

  108. Nair V, Sharma A, Ratheesh J, Das S, Mishra DK, Kale R et al. Severe intravascular haemolysis following minor group mismatched peripheral blood stem cell transplantation. Bone Marrow Transplant 2007; 39: 805–806.

    Article  CAS  PubMed  Google Scholar 

  109. Tiplady CW, Fitzgerald JM, Jackson GH, Conn JS, Proctor SJ . Massive haemolysis in a group A recipient of a group O peripheral blood stem cell allogeneic transplant. Transfus Med 2001; 11: 455–458.

    Article  CAS  PubMed  Google Scholar 

  110. Noborio K, Muroi K, Izumi T, Toshima M, Kawano-Yamamoto C, Otsuki T et al. Massive immune hemolysis after non-myeloablative allogeneic peripheral blood stem cell transplantation with minor ABO-incompatibility. Leuk Lymph 2003; 44: 357–359.

    Article  CAS  Google Scholar 

  111. Lee HJ, Gulbis A, DePadua Silva L, Hosing C, Khouri I, deLima M et al. Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT. Bone Marrow Transplant 2008; 42: 67–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Salmon JP, Michaux S, Hermanne JP, Baudoux E, Gerard C, Sontag-Thull D et al. Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation. Transfusion 1999; 39: 369–373.

    Article  Google Scholar 

  113. Laurencet FM, Samii K, Bressoud A, Tajeddin M, Easton J, Stelling MJ et al. Massive delayed hemolysis following peripheral blood stem cell transplantation with minor ABO incompatibility. Hematol Cell Ther 1997; 39: 159–162.

    Article  CAS  PubMed  Google Scholar 

  114. Bornhauser M, Ordemann R, Paaz U, Schuler U, Kompf J, Holig K et al. Rapid engraftment after allogeneic ABO-incompatible peripheral blood progenitor cell transplantation complicated by severe hemolysis. Bone Marrow Transplant 1997; 19: 295–297.

    Article  CAS  PubMed  Google Scholar 

  115. Bolan CD, Childs RW, Procter JL, Barrett AJ, Leitmann SF . Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility. Br J Haemataol 2001; 112: 787–795.

    Article  CAS  Google Scholar 

  116. Toren A, Dacosta Y, Manny N, Varadi G, Or R, Nagler A . Passenger B-lymphocyte-induced severe hemolytic disease after allogeneic peripheral blood stem cell transplantation (letter). Blood 1996; 87: 843–844.

    CAS  PubMed  Google Scholar 

  117. Oziel-Taieb S, Faucher-Barbey C, Chabannon C, Ladaique P, Saux P, Souin F et al. Early and fatal immune haemolysis after so-called ‘minor’ ABO-incompatible peripheral blood stem cell allotransplantation. Bone Marrow Transplant 1997; 19: 1155–1156.

    Article  CAS  PubMed  Google Scholar 

  118. Gajewski JL, Petz LD, Calhoun L, O’Rourke S, Landaw EM, Lyddane NR et al. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate. Blood 1992; 79: 3076–3085.

    CAS  PubMed  Google Scholar 

  119. Worel N, Greinix HT, Keil F, Mittenbauer M, Lechner K, Fischer G et al. Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning. Transfusion 2002; 42: 1293–1301.

    Article  PubMed  Google Scholar 

  120. Lapierre V, Oubouxar N, Auperin A, Tramalloni D, Tayebi H, Robinet E et al. Influence of the hematopoietic stem cell source on early immunohematologic reconstitution after allogeneic transplantation. Blood 2001; 97: 2580–2586.

    Article  CAS  PubMed  Google Scholar 

  121. Worel N, Greinix HT, Supper V, Leitner G, Mitterbauer M, Rabitsch W et al. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning. Transfusion 2007; 47: 1494–1502.

    Article  PubMed  Google Scholar 

  122. Josephson CD, Castillejo MI, Grima K, Hillyer CD . ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies. Transfus Apher Sci 2010; 42: 83–88.

    Article  PubMed  Google Scholar 

  123. Josephson CD, Mullis NC, Van Demark C, Hillyer CD . Significant number of apheresis-derived group O platelets units have ‘high titer’ anti-A/A,B: Implications for transfusion policy. Transfusion 2004; 44: 805–808.

    Article  CAS  PubMed  Google Scholar 

  124. Garraty G . Problems associated with passively transfused blood group alloantibodies. Am J Clin Pathol 1998; 109: 769–777.

    Article  Google Scholar 

  125. Lapierre V, Kuentz M, Tiberghien P, for Societe Francaise de Greffe de Moelle. Allogeneic peripheral blood hematopoietic stem cell transplantation: guidelines for red blood cell immuno-hematological assessment and transfusion practice. Bone Marrow Transplant 2000; 25: 507–512.

    Article  CAS  PubMed  Google Scholar 

  126. Heddle NM, O’Hoski P, Singer J, McBride JA, Ali MA, Kelton JG . A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing. Br J Haematol 1992; 81: 579–584.

    Article  CAS  PubMed  Google Scholar 

  127. Judd WJ, Fullen DR, Steiner EA, Cavenport RD, Knafl PC . Revisiting the issue: can the reading for serologic reactivity following 37 degrees C incubation be omitted? Transfusion 1999; 39: 295–299.

    Article  CAS  PubMed  Google Scholar 

  128. Chapman JF, Milkins C, Voak D . The computer crossmatch: a safe alternative to the serological crossmatch. Transfus Med 2000; 10: 251–256.

    Article  CAS  PubMed  Google Scholar 

  129. McLeod BC, Piehl MR, Sassetti RJ . Alloimmunizaation to RhD by platelet transfusion in autologous bone marrow transplant recipients. Vox Sang 1990; 59: 185–189.

    Article  CAS  PubMed  Google Scholar 

  130. Asfour M, Narvios A, Lichtiger B . Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients. Med Gen Med 2004; 6: 22.

    Article  CAS  Google Scholar 

  131. Mijovic A . Alloimmunization to RhD antigen in RhD-incompatible haemopoietic cell transplants with non-myeloablative conditioning. Vox Sang 2002; 83: 358–362.

    Article  PubMed  Google Scholar 

  132. Avache S, Herman JH . Prevention of D sensitization after mismatched transfusion of blood components: toward optimal use of RhIG. Transfusion 2008; 48: 1990–1999.

    Article  Google Scholar 

  133. Heal JM, Liesveld JL, Phillips GL, Blumberg N . What would Karl Landsteiner do? The ABO blood group and stem cell transplantation. Bone Marrow Transplant 2005; 36: 747–755.

    Article  CAS  PubMed  Google Scholar 

  134. Lapierre V, Mahe C, Auperin A, Stambouli F, Oubouzar N, Tramalloni D et al. Platelet transfusion containing ABO-incompatible plasma and hepatic veno-occlusive disease after hematopoietic transplantation in young children. Transplantation 2005; 80: 314–319.

    Article  PubMed  Google Scholar 

  135. International Standards for Cellular Therapy Product Collection. Processing, and Administration, 4th edn. Foundation for the Accreditation of Cellular Therapy: Omaha, NE.

  136. Raimondi R, Soli M, Lamparelli T, Bacigalupo A, Arcese W, Belloni M et al. ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature. Bone Marrow Transplant 2004; 34: 321–329.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Carolyn Magnani for her dedicated and skilled assistance in preparing this manuscript.

Author information

Authors and Affiliations

  1. Adult Blood and Marrow Transplantation Program, John Theurer Cancer Center, Hackensack, NJ, USA

    S D Rowley & M L Donato

  2. Department of Pathology, Hackensack University Medical Center, Hackensack, NJ, USA

    P Bhattacharyya

Authors
  1. S D Rowley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M L Donato
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P Bhattacharyya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S D Rowley.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rowley, S., Donato, M. & Bhattacharyya, P. Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation. Bone Marrow Transplant 46, 1167–1185 (2011). https://doi.org/10.1038/bmt.2011.135

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2011.135

Keywords

This article is cited by

Search

Advanced search

Quick links